Research interests include Epigenetics and DNA Methylation, RNA modifications and cancer, Cancer-related molecular mechanisms research, and Cancer-related gene regulation.
JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma